Next, we sought to test the influence of TACC3 on EGFR signaling in NSCLC cells and tested whether the targeting of TACC3 has an effect on NSCLC cells that are resistant to TKI treatment. This evidence concerns the gene EGFR and non-small cell lung carcinoma.